Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Telo Genomics Corp (TELO) Stock Price & Analysis

TELO Stock Chart & Stats

CA$0.05CA$0.00(0.00%)
At close: 4:00 PM EST
C$0.04C$0.05C$0.06C$0.0730 Jul17 Aug2 Sep15 Sep28 Sep13 Oct26 Oct
Day’s Range
CAD 0.05 - CAD 0.06
52-Week Range
CAD 0.03 - CAD 0.11
Previous Close
CAD 0.05
Volume
N/A
Average Volume (3M)
63.42K
Market Cap
CAD 5.02M
Enterprise Value
CAD 5.86M
Total Cash (Recent Filing)
CAD 338.32K
Total Debt (Recent Filing)
CAD 1.44M
Price to Earnings (P/E)
―
Beta
1.10
Next Earnings
Nov 19, 2026 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Specialized Diagnostic Platform

The TeloView platform gives Telo Genomics a defined technology base centered on telomere biology, with potential applications across oncology and hematology. This focused diagnostic capability can support development of specialized clinical and research products as the company advances commercialization.

Improving Cash Burn

The year-over-year reduction in operating cash burn indicates some improvement in cost control or operating efficiency, even though cash usage remains substantial. If maintained, this trend could extend the company’s funding runway and reduce the pace at which external capital is required.

Losses Stabilized In 2026

The modest reduction in net loss suggests that deterioration did not continue in the latest period, providing an early indication of stabilization. Sustaining this improvement would help management control the cost base while the company works toward revenue generation and operating leverage.

Bears Say

No Revenue Generation

The absence of reported revenue over multiple years indicates that Telo Genomics has not yet established commercial traction for its diagnostic offerings. Without recurring product or service sales, the company lacks an internal revenue engine to fund operations, validate demand, or support scalable profitability.

Negative Equity And Rising Debt

Negative equity combined with newly increased debt materially weakens the company’s financial cushion and limits flexibility. This capital structure leaves less capacity to absorb setbacks or invest in development internally, while debt adds obligations before the business has demonstrated revenue traction.

Persistent Cash Dependence

Although cash burn improved, the company continues to consume cash through operations and has not reached self-funding status. Ongoing negative free cash flow means progress depends on securing external capital, which can constrain strategic choices and increase financing pressure over the next several quarters.

Telo Genomics Corp News

TELO FAQ

What was Telo Genomics Corp’s price range in the past 12 months?
Telo Genomics Corp lowest stock price was C$0.03 and its highest was C$0.11 in the past 12 months.
What is Telo Genomics Corp’s market cap?
Telo Genomics Corp’s market cap is C$5.02M.
When is Telo Genomics Corp’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Telo Genomics Corp’s earnings last quarter?
Telo Genomics Corp released its earnings results on Jun 02, 2026. The company reported -C$0.006 earnings per share for the quarter.
Is Telo Genomics Corp overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Telo Genomics Corp pay dividends?
Telo Genomics Corp does not currently pay dividends.
What is Telo Genomics Corp’s EPS estimate?
Telo Genomics Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Telo Genomics Corp have?
Telo Genomics Corp has 100,430,470 shares outstanding.
What happened to Telo Genomics Corp’s price movement after its last earnings report?
Telo Genomics Corp reported an EPS of -C$0.006 in its last earnings report. Following the earnings report the stock price went down -5.66%.
Which hedge fund is a major shareholder of Telo Genomics Corp?
Currently, no hedge funds are holding shares in TSE:TELO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology